Trazodone use and risk of dementia: A population-based cohort study.
<h4>Background</h4>In vitro and animal studies have suggested that trazodone, a licensed antidepressant, may protect against dementia. However, no studies have been conducted to assess the effect of trazodone on dementia in humans. This electronic health records study assessed the associ...
Main Authors: | Ruth Brauer, Wallis C Y Lau, Joseph F Hayes, Kenneth K C Man, David P J Osborn, Robert Howard, Joseph Kim, Ian C K Wong |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2019-02-01
|
Series: | PLoS Medicine |
Online Access: | https://doi.org/10.1371/journal.pmed.1002728 |
Similar Items
-
Impact of the COVID‐19 pandemic on use of anti‐dementia medications in 34 European and North American countries
by: Chengsheng Ju, et al.
Published: (2021-01-01) -
Trazodone for the treatment of sleep disorders in dementia: an open-label, observational and review study
by: Einstein Francisco Camargos, et al.
Published: (2011-02-01) -
Estimation of an Appropriate Dose of Trazodone for Pediatric Insomnia and the Potential for a Trazodone–Atomoxetine Interaction
by: Laura Oggianu, et al.
Published: (2020-02-01) -
Alleviation of neuropathic pain by trazodone in rats
by: Rajalakshimi Vasudevan, et al.
Published: (2022-05-01) -
The association between dementia and the risk of hypoglycaemia events among patients with diabetes mellitus: a propensity-score matched cohort analysis
by: Alaa A. Alsharif, et al.
Published: (2023-07-01)